MedTrace Logo

CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF)

NCT07380828 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2026-02-02

No results posted yet for this study

Summary

Study aims to investigate the incidence, associations and prognostic value of CRGM and its components: chronic kidney disease, type 2 diabetes, atherosclerotic cardiovascular diseases, and non-alcoholic fatty liver disease in patients with different phenotypes and severity of clinical manifestations of CHF.

Conditions

Sponsors & Collaborators

  • Russian Scientific Medical Society of Therapists

    lead OTHER

Principal Investigators

  • Oxana Drapkina, doctor of sciences · National Medical Research Center for Terapy and Preventive Medicine

  • Anna Chesnikova, doctor of sciences · Rostov-on-Don State Medical Univercity

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2029-04-30
Completion
2029-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07380828 on ClinicalTrials.gov